Quaker Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Quaker Wealth Management's BMY Position: Q3 2026 in Review
Quaker Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q3 2026, buying an estimated $8.53K and bringing the position to 2,273 shares worth $142K. The position accounts for 0.04% of the portfolio, ranked #96.
Quaker Wealth Management first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $344K in Q3 2023. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Quaker Wealth Management held 2,273 shares of Bristol-Myers Squibb worth $142K as of Q3 2026.
- Quaker Wealth Management bought 135 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.53K.
- Bristol-Myers Squibb made up 0.04% of Quaker Wealth Management's portfolio in Q3 2026, its #96 holding.
- Quaker Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
- Quaker Wealth Management's Bristol-Myers Squibb position peaked at $344K in Q3 2023.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.